Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR‐Ts: new perspectives in cancer therapy
Rafaela Abrantes, Henrique O. Duarte, Catarina Gomes, et al.
FEBS Letters (2022) Vol. 596, Iss. 4, pp. 403-416
Closed Access | Times Cited: 23

Showing 23 citing articles:

CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo
Vita M. Golubovskaya, John Sienkiewicz, Jinying Sun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13364-13364
Open Access | Times Cited: 22
Proximity Labeling: Precise Proteomics Technology for Mapping Receptor Protein Neighborhoods at the Cancer Cell Surface
Saman Rahmati, Andrew Emili
Cancers (2025) Vol. 17, Iss. 2, pp. 179-179
Open Access
Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Arunraj Namachivayam, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1493-1493
Open Access | Times Cited: 30
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Tarak Chouari, Francesca Soraya La Costa, Nabeel Merali, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4265-4265
Open Access | Times Cited: 18
Biomarkers and biosensors for early cancer diagnosis, monitoring and prognosis
Mugip Rahaman Abdul Wahab, Thirunavukkarasu Palaniyandi, Maddaly Ravi, et al.
Pathology - Research and Practice (2023) Vol. 250, pp. 154812-154812
Closed Access | Times Cited: 11
Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update
Samaneh Jahandar-Lashaki, Safar Farajnia, Aref Faraji-Barhagh, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
Anti-glycan monoclonal antibodies: Basic research and clinical applications
Kara M. Gillmann, J. Sebastian Temme, Samantha Marglous, et al.
Current Opinion in Chemical Biology (2023) Vol. 74, pp. 102281-102281
Open Access | Times Cited: 10
Advances in the Immunomodulatory Properties of Glycoantigens in Cancer
Valeria da Costa, Teresa Freire
Cancers (2022) Vol. 14, Iss. 8, pp. 1854-1854
Open Access | Times Cited: 17
Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?
Emile Verhulst, Delphine Garnier, Ingrid De Meester, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 624-624
Open Access | Times Cited: 16
CAR-T Cells Targeting Immune Checkpoint Pathway Players
Vita M. Golubovskaya
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 4
Open Access | Times Cited: 13
Role of tumor cell sialylation in pancreatic cancer progression
Michael P. Marciel, Barnita Haldar, Jihye Hwang, et al.
Advances in cancer research (2022), pp. 123-155
Open Access | Times Cited: 12
Synthetic Biology Meets Ca2+ Release-Activated Ca2+ Channel-Dependent Immunomodulation
Bernadett Bacsa, Valentina Hopl, Isabella Derler
Cells (2024) Vol. 13, Iss. 6, pp. 468-468
Open Access | Times Cited: 1
Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma
Ayşe Sedef Köseer, Liliana R. Loureiro, Justyna Jureczek, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1677-1677
Open Access | Times Cited: 9
Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?
Mariana Tannoury, Delphine Garnier, Santos A. Susín, et al.
Cancers (2022) Vol. 14, Iss. 24, pp. 6026-6026
Open Access | Times Cited: 8
Immune evasion by cancer stem cells ensures tumor initiation and failure of immunotherapy
Sourio Chakraborty, Sumon Mukherjee, Udit Basak, et al.
Exploration of Immunology (2023), pp. 384-405
Open Access | Times Cited: 2
Editorial on “Cell Therapy, Bispecific Antibodies and Other Immunotherapies against Cancer”
Vita M. Golubovskaya
Cancers (2023) Vol. 15, Iss. 20, pp. 5053-5053
Open Access | Times Cited: 2
Engineered CAR-T cells: An immunotherapeutic approach for cancer treatment and beyond
Purva Khodke, Bajarang Vasant Kumbhar
Advances in protein chemistry and structural biology (2024), pp. 157-198
Closed Access
T cell receptor signaling and cell immunotherapy
Linsong Zhang, Xinyi Xu, Xiaoshan Shi, et al.
National Science Open (2024) Vol. 3, Iss. 4, pp. 20230087-20230087
Open Access
Metastatic organotropism: a brief overview
Margarida Carrolo, João A. I. Miranda, Guilherme Vilhais, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Omics Applications in Cancer Immunology
Cornelia Braicu, Cecilia Bica, Laura Pop, et al.
Springer eBooks (2024), pp. 1-20
Closed Access
Drug discovery: Standing on the shoulders of giants
Susan M. Miller, Walter H. Moos, Barbara H. Munk, et al.
Elsevier eBooks (2023), pp. 207-338
Closed Access
Gastrointestinal Side Effects of Anticancer Therapy
José Antonio Uranga, Kulmira Nurgali, Raquel Abalo
Springer eBooks (2023), pp. 1-36
Closed Access
Updating CAR-T Cell Immunotherapy for Liquid and Solid Tumor
Ankita Singh, Pravin D. Potdar
Diseases & Research (2023) Vol. 3, Iss. 2, pp. 110-120
Open Access
Page 1

Scroll to top